The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an actively managed fund that invests in companies developing GLP-1 and other weight loss drugs, targeting the global weight management industry. The ETF, which launched on May 21, 2024, has an expense ratio of 0.59% and currently manages $55.89 million in assets. OZEM’s price has shown recent declines but a significant increase over the last year, and it pays dividends with a 1.21% yield.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
OZEM Stock Fund Price and Chart — NASDAQ:OZEM
The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an actively managed fund that invests in companies developing GLP-1 and other weight loss drugs, targeting the global weight management industry. The ETF, which launched on May 21, 2024, has an expense ratio of 0.59% and currently manages $55.89 million in assets. OZEM’s price has shown recent declines but a significant increase over the last year, and it pays dividends with a 1.21% yield.